GAO Recommends Further Revamp Of DME Competitive Bidding Program
This article was originally published in The Gray Sheet
Suppliers of durable medical equipment should have more opportunity to question their bid results in the Medicare DME competitive bidding process, according to a November report to Congress made public Dec. 7 by the General Accounting Office
You may also be interested in...
An embattled durable medical equipment prosthetics, orthotics and supplies (DMEPOS) competitive bidding program that just got off the ground will likely come to a halt in the coming weeks now that Congress has passed a broad-based Medicare bill
The regulatory agency also urges qualified persons at drug companies to let the agency know as soon as possible if they are finding that the new measures are not flexible enough to deal with the current logistical challenges quickly.
The Swiss biotech's focal-onset seizure therapy, which is licensed from South Korea's SK and is already approved in the US, could have potential in indications beyond epilepsy, Arvelle's CEO tells Scrip.